Here Are the Facts You Need to Understand UNH

Shares of Health Care sector company UnitedHealth moved -0.5% today, and are now trading at a price of $523.82. The large-cap stock's daily volume was 2,469,502 compared to its average volume of 2,974,360. The S&P 500 index returned a 1.0% performance.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company is based in Minnetonka and has 400,000 full time employees. Its market capitalization is $484,494,213,120. UnitedHealth currently offers its equity investors a dividend that yields 1.3% per year.

23 analysts are following UnitedHealth and have set target prices ranging from $440.56 to $619.53 per share. On average, they have given the company a rating of buy. At today's prices, UNH is trading -3.61% away from its average analyst target price of $543.44 per share.

Over the last year, UNH's share price has increased by 1.2%, which represents a difference of -22.8% when compared to the S&P 500. The stock's 52 week high is $554.7 per share whereas its 52 week low is $445.68. With average free cash flows of $19.98 Billion that have been growing at an average rate of 10.7% over the last 6 years, UnitedHealth is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 29,728,000 3,293,000 26,435,000 12.95
2022 26,206,000 2,802,000 23,404,000 17.67
2021 22,343,000 2,454,000 19,889,000 -1.16
2020 22,174,000 2,051,000 20,123,000 22.76
2019 18,463,000 2,071,000 16,392,000 20.09
2018 15,713,000 2,063,000 13,650,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.